AKT1 and MAPK8: New Targets for Gestational Diabetes Mellitus?

<b>Objective:</b> Gestational diabetes mellitus (GDM) disrupts placental function and increases risks for pregnancy. This study investigates the potential involvement of AKT1 and MAPK8 genes, known for their roles in insulin resistance and cell signaling, in GDM pathophysiology. <b>Methods:</b> Placental tissues from GDM patients and healthy controls were analyzed using real-time PCR to quantify gene expression levels. In silico analysis further explored the functional implications of expression changes. <b>Results:</b> AKT1 and MAPK8 displayed significantly altered expression in GDM placentas compared to controls (<i>p</i> = 0.047 and <i>p</i> = 0.007, respectively). In silico analysis suggests potential functional consequences related to diabetes-associated pathways. <b>Conclusion:</b> This study identifies differential expression of AKT1 and MAPK8 in GDM placentas, suggesting their potential roles in the disease process. Further investigation into their functional contributions could provide valuable insights into GDM pathophysiology and potential therapeutic targets.